Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

More than 1,000 grand jury presentations are under review after federal prosecutors in Chicago were forced to dismiss charges in the "Broadview Six" case due to grand jury abuses and prosecutorial ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Over the past few years, I've gone through hundreds of interviews in English while looking for opportunities abroad. I've presented my work to designers, managers, product leaders, and design leads ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for ...

Sitting on low benches, casually talking, dressed in comfortable clothes, and surrounded by books, design objects, and works of art, Charles and Ray Eames appear in one of the most emblematic images ...

Exelixis, Inc. (Nasdaq: EXEL) today announced presentations for its flagship product, CABOMETYX® (cabozantinib), and its investigational oral kinase inhibitor, zanzalintinib, at the 2026 American ...

The 14th annual Inkjet Summit wrapped up Wednesday night, April 29, with an awards banquet at the Hyatt Regency Hill Country Resort and Spa in San Antonio, Texas. It was the largest Inkjet Summit yet, ...

Adobe Acrobat has largely catered to professionals with its recent AI features. Now, the company is turning its attention to students by making Acrobat more useful with the launch of a new AI tool ...

SAN FRANCISCO, March 20, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic dermatitis and alopecia ...

London, UK, 19 March 2026 - Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic Low Back Pain (cLBP), today announces ...